Literature DB >> 11127148

muc-1 gene expression in head and neck squamous cell carcinomas.

J S Rubin1, B K Bloor, I R Hart, P R Morgan.   

Abstract

Polymorphic epithelial mucin (PEM), the protein product of the gene muc-1, is a surface glycoprotein that is produced by a range of normal epithelial cells, but has been shown to be expressed at high levels in a range of adenocarcinomas. It has not been investigated extensively in head and neck related tissues, and not at all in head and neck squamous cell carcinomas (HNSCC). This immunohistochemical investigation using two monoclonal antibodies to muc-1 represents a baseline study of 18 HNSCC. In 13 cases, the glycoprotein was expressed at varying levels, usually in keratinizing foci. Although less prominent, expression was also present to some degree in nine of 23 control specimens of non-neoplastic mucosa, mostly at an epithelial level early in the parakeratinization process. Both antibodies showed a pattern of staining. The cellular basis for muc-1 expression is speculative at present and although it is at a lower level than in adenocarcinomas, it may help to provide further insight into epithelial cell differentiation in squamous cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127148     DOI: 10.1258/0022215001904121

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  4 in total

1.  MUC1 mucin and carbohydrate associated antigens as tumor markers in head and neck squamous cell carcinoma.

Authors:  M V Croce; M E Rabassa; M R Price; A Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

2.  Influence of sialic acid removal on MUC1 antigenic reactivity in head and neck carcinoma.

Authors:  María V Croce; Martín E Rabassa; Adrián Pereyra; Amada Segal-Eiras
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

3.  Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis.

Authors:  Alexander Gelbard; Charlie T Garnett; Scott I Abrams; Vyomesh Patel; J Silvio Gutkind; Claudia Palena; Kwong-Yok Tsang; Jeffrey Schlom; James W Hodge
Journal:  Clin Cancer Res       Date:  2006-03-15       Impact factor: 12.531

4.  The Reversal of Immune Exclusion Mediated by Tadalafil and an Anti-tumor Vaccine Also Induces PDL1 Upregulation in Recurrent Head and Neck Squamous Cell Carcinoma: Interim Analysis of a Phase I Clinical Trial.

Authors:  Donald T Weed; Serena Zilio; Isildinha M Reis; Zoukaa Sargi; Marianne Abouyared; Carmen R Gomez-Fernandez; Francisco J Civantos; Carla P Rodriguez; Paolo Serafini
Journal:  Front Immunol       Date:  2019-05-31       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.